Medtronic v. Boston Scientific: Appeals Court Affirms Taxus Non-Infringement
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Taxus, Express and NIR stents do not infringe four Medtronic stent design patents, the U.S. Court of Appeals for the Federal Circuit affirms in a May 26 ruling
You may also be interested in...
Medtronic Stent Patent Ruling Makes DES Vulnerable; Will Guidant Cut Deal?
Medtronic will appeal a Delaware federal court patent infringement ruling against its Driver and S7 coronary stents and challenge the validity of Guidant's Lau patent, the firm says
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.